Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions by Zhang, S, Nguyen, T D, Hurtado Rúa, S M, Kaunzner, U W, Pandya, S, Kovanlikaya, I, Spincemaille, P, Wang, Y, Gauthier, S A

Get full text

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity by Shinoda, Koji, Li, Rui, Rezk, Ayman, Mexhitaj, Ina, Patterson, Kristina R, Kakara, Mihir, Zuroff, Leah, Bennett, Jeffrey L, von Büdingen, H-Christian, Carruthers, Robert, Edwards, Keith R, Fallis, Robert, Giacomini, Paul S, Greenberg, Benjamin M, Hafler, David A, Ionete, Carolina, Kaunzner, Ulrike W, Lock, Christopher B, Longbrake, Erin E, Pardo, Gabriel, Piehl, Fredrik, Weber, Martin S, Ziemssen, Tjalf, Jacobs, Dina, Gelfand, Jeffrey M, Cross, Anne H, Cameron, Briana, Musch, Bruno, Winger, Ryan C, Jia, Xiaoming, Harp, Christopher T, Herman, Ann, Bar-Or, Amit

Get full text

Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions by Pandya, Sneha, Kaunzner, Ulrike W, Hurtado Rúa, Sandra M, Nealon, Nancy, Perumal, Jai, Vartanian, Timothy, Nguyen, Thanh D., Gauthier, Susan A

Get full text

Identification of novel CSF measures of disease activity and chronic progressive biology in MS: results of the Ocrelizumab Biomarker Outcome Evaluation Study (OBOE): a randomised,... by Cross, AH, Gelfand, JM, Bennett, JL, von Budingen, HC, Cameron, B, Carruthers, R, Edwards, K, Fallis, R, Gerstein, R, Giacomini, PS, Greenberg, B, Hafler, DA, Ionete, C, Kaunzner, UW, Kodama, L, Lock, C, Longbrake, EE, Musch, B, Pardo, G, Piehl, F, Weber, MS, Yuen, S, Ziemssen, T, Winger, RC, Jia, X, Herman, AE, Harp, C, Bar-Or, A

Get full text

Brain dendritic cells in ischemic stroke by Felger, J C, Abe, T, Kaunzner, U W, Gal-Toth, J, Gottfried-Blackmore, A, McEwen, B S, Iadecola, C, Bulloch, K

Get full text

Cellular immune profiling pre- and post-aCD20 therapy points to differential effects on CD4 + and CD8 + T cells and implicates CD20-expressing CD8 + T cells in MS disease activity by Shinoda, K, Li, R, Rezk, A, Mexhitaj, I, Patterson, KR, Kakara, M, Zuroff, L, Bennett, JL, von Budingen, HC, Carruthers, R, Edwards, KR, Fallis, R, Giacomini, PS, Greenberg, B, Hafler, DA, Ionete, C, Kaunzner, UW, Lock, CB, Longbrake, EE, Pardo, G, Piehl, F, Weber, M, Ziemssen, T, Gelfand, JM, Cross, AH, Cameron, B, Musch, B, Winger, R, Jia, X, Harp, C, Herman, A, Bar-Or, A

Get full text

Biomarker Changes in Relapsing Multiple Sclerosis (RMS) patients after B cell Depletion with Ocrelizumab by Cross, AH, Harp, CT, Bennett, JL, von Budingen, HC, Carruthers, R, Edwards, K, Eggers, E, Fallis, R, Fiore, D, Gelfand, JM, Giacomini, PS, Greenberg, BM, Hafler, DA, Longbrake, EE, Assman, B, Ionete, C, Kaunzner, UW, Lock, C, Ma, X, Musch, B, Pardo, G, Piehl, F, Weber, MS, Ziemssen, T, Herman, AE, Bar-Or, A

Get full text